

| Número de catálogo | HM833013 | ||||
|---|---|---|---|---|---|
| Reactividad de especies | Human | ||||
| Aplicaciones | ELISA, FCM | ||||
| Especie huésped | Mouse | ||||
| Clonalidad | Monoclonal | ||||
| Isotipo | IgG1 | ||||
| ID de clon | 3PF12 | ||||
| Objetivo | HLAA, Human leukocyte antigen A, HLA class I histocompatibility antigen, A alpha chain, HLA-A | ||||
| Nivel de endotoxinas | Please contact with the lab for this information. | ||||
| Pureza | >95% as determined by SDS-PAGE. | ||||
| Purificación | Protein A/G purified from cell culture supernatant. | ||||
| Número de acceso | P04439 | ||||
| RRID | Anti-Human HLA-A2 Antibody (3PF12) (abinScience Cat# HM833013, RRID:AB_3727811) |
||||
| Forma | Liquid | ||||
| Buffer de almacenamiento | 0.01M PBS pH 7.4 Consulte la información específica del buffer en la copia impresa del datasheet o en el COA específico del lote. |
||||
| Información de uso del producto |
| ||||
| Estabilidad y almacenamiento | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. | ||||
| Fondo | HLA class I histocompatibility antigen, A alpha chain (HLA-A2) is a ~40 kDa protein. Antigen-presenting major histocompatibility complex class I (MHCI) molecule. In complex with B2M/beta 2 microglobulin displays primarily viral and tumor-derived peptides on antigen-presenting cells for recognition by alpha-beta T cell receptor (TCR) on HLA-A-restricted CD8-positive T cells, guiding antigen-specific T cell immune response to eliminate infected or transformed cells. May also present self-peptides derived from the signal sequence of secreted or membrane proteins, although T cells specific for these peptides are usually inactivated to prevent autoreactivity. Both the peptide and the MHC molecule are recognized by TCR, the peptide is responsible for the fine specificity of antigen recognition and MHC residues account for the MHC restriction of T cells. Typically presents intracellular peptide antigens of 8 to 13 amino acids that arise from cytosolic proteolysis via IFNG-induced immunoproteasome or via endopeptidase IDE/insulin-degrading enzyme. 1. Fukada, K. et al. (1999) AIDS (London, England) 13, 1413-4. PMID: 10449296 2. Nagata, Y. et al. (2002) Proceedings of the National Academy of Sciences of the United States of America 99, 10629-34. PMID: 12138174 3. Kuzushima, K. et al. (2003) Blood 101, 1460-8. PMID: 12393434 4. Traversari, C. et al. (1992) The Journal of experimental medicine 176, 1453-7. PMID: 1402688 5. Satoh, M. et al. (2005) Vaccine 23, 3783-90. PMID: 15893615 6. Asemissen, AM. et al. (2006) Clinical cancer research : an official journal of the American Association for Cancer Research 12, 7476-82. PMID: 17189421 7. Hadrup, SR. et al. (2009) Nature methods 6, 520-6. PMID: 19543285 8. Matthews, PC. et al. (2011) Journal of immunology (Baltimore, Md. : 1950) 186, 5675-86. PMID: 21498667 9. Shimizu, A. et al. (2013) Scientific reports 3, 3097. PMID: 24192765 10. Quiñones-Parra, S. et al. (2014) Proceedings of the National Academy of Sciences of the United States of America 111, 1049-54. PMID: 24395804 | ||||
| Nota | For research use only. |

SDS-PAGE for Anti-Human HLA-A2 Antibody (3PF12).




Contáctenos para cotizaciones personalizadas, solicitudes en masa y cualquier otro problema.
Correo: [email protected]


+86-027-65523339
Edificio C, No. 666, Calle Shendunsi, Wuhan, 430206, China
中文
English
한국어
日本語
Español
Français
Русский